Ever since Hillary Clinton tweeted her disdain for price gouging - or the practice of raising the …

This hearing is not to demonize capitalists or destroy free markets. These hearings are really grap…

ValueAct, which grew into a highly regarded fund, in no small measure due to the huge success of it…

Overall, we believe that Valeant's self-proclaimed "new business model" for pharma has been reliant…

"Is the task of growing from $1 billion to $40 billion in six years more difficult than the task of…

There's movement on the US House of Representatives' action against the company as well. The Commit…

In the meantime, Valeant's stock will continue to fall. It has lost 23% of its value in the last fi…

This insider trading case has nothing to do with any of those issues. Instead, its about Valeant…

"Well, I just asked Mr. Ackman about that and he says that that is not accurate. My staff gave me a…

Now, in 2017, Ackman will pay the lion's share to settle insider-trading claims. It's understandabl…

In March, Valeant's stock got hit hard after the company reported fourth-quarter earnings results t…

We believe that a drug company can do as much or more for innovation in pharma by acquiring other d…

South Korean marines guarding the Han river, which flows into an estuary and meets the North's Imji…

Lots of businesses can become political punching bags for their pricing. But when oil companies or …

"We're already seeing North Korea starting to issue threats: If the US doesn't stop these exercises…

1. Baxter of California deodorant, $18; baxterofcalifornia.com 2. Fernwood container by Labrazel H…

This year, Kim Jong Un has threatened the United States with nuclear attack, declared a "state of w…

Last year, Ackman unsuccessfully tried to help Valeant buy Allergan, another pharmaceutical company…

That, according to the Financial Times, is what Berna Wilson experienced when Valeant increased the…

Netflix is getting smoked after earnings. The home-entertainment provider announced earnings of $0.…